Yaccarino has taken over as CEO of eMed Population Health, succeeding Wendy Mader. The company focuses on GLP-1 drugs used to address diabetes and obesity. Yaccarino aims to leverage technology, lifestyle, and data to create impactful digital channels for consumers. Under her leadership, eMed plans to enhance partnerships with employers and governments. Her experience in developing strategic partnerships and understanding of complex markets is expected to establish eMed as a leader in population health solutions.
Driving the news: Yaccarino is the new CEO of eMed Population Health, a telehealth focused on GLP-1s, the blockbuster drugs used to treat diabetes and obesity.
Yaccarino comes on board as eMed is aiming to expand partnerships with employers and governments.
Her ability to forge game-changing partnerships and navigate complex markets will position the company to become the definitive global leader in population health solutions.
Collection
[
|
...
]